Suzhou Fushilai Pharmaceutical Co., Ltd.

SZSE:301258 Stock Report

Market Cap: CN¥2.4b

Suzhou Fushilai Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Suzhou Fushilai Pharmaceutical has a total shareholder equity of CN¥1.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.1B and CN¥187.4M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥1.38b
EquityCN¥1.89b
Total liabilitiesCN¥187.38m
Total assetsCN¥2.08b

Recent financial health updates

No updates

Recent updates

There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Oct 30
There May Be Reason For Hope In Suzhou Fushilai Pharmaceutical's (SZSE:301258) Disappointing Earnings

Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

Jun 07
Suzhou Fushilai Pharmaceutical (SZSE:301258) Is Increasing Its Dividend To CN¥0.6005

Financial Position Analysis

Short Term Liabilities: 301258's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥126.2M).

Long Term Liabilities: 301258's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥61.2M).


Debt to Equity History and Analysis

Debt Level: 301258 is debt free.

Reducing Debt: 301258 had no debt 5 years ago.

Debt Coverage: 301258 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301258 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies